Primary duties:
C. L. de Carvalho-Heineken Prize recognizes his seminal work in the cognition of music
Cognitive neuroscientist Robert Zatorre has been awarded the C.L. de Carvalho-Heineken Prize in Cognitive Sciences.
The Heineken Prize–given every two years to five different researchers–is considered the most prestigious international science prize in The Netherlands and includes a monetary reward of US$200,000. Previous winners include Nancy Kanwisher of MIT, and Stanislas Dehaene of the Collège de France.
Award recognizes his collaborative work in neuroscience and neuroinformatics
Neuroscientist Alan Evans has been awarded the Killam Prize, one of Canada’s highest honours, for his numerous contributions to the understanding of the human brain.
Evans is an internationally recognized researcher at The Neuro (Montreal Neurological Institute-Hospital), James McGill Professor in Neurology and Neurosurgery and the Victor Dahdaleh Chair in Neurosciences.
The Neuro proudly supports the Open COVID Pledge, which calls on academic institutions, industry, and other organizations to make their intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing its impact.
As the world’s first Open Science institution, The Neuro is committed to the open exchange of ideas, technologies and resources, in order to remove barriers to discovery.
Montreal medical specialists and 3D printing company team up to find solutions for critical supply shortages
The COVID-19 pandemic has created an unprecedented need to provide personal protective equipment (PPE) for hospital staff. A team of Montreal medical experts has partnered with a 3D printing company to design and distribute face shields to protect healthcare workers as they treat patients with this life-threatening disease.
The Neuro’s director has been a driving force in neurological disease research and Open Science leadership
Since 1957, The Gairdner Foundation has been recognizing the achievements of the world’s top researchers for their contributions to health science. This year, Dr. Guy Rouleau joins an elite group of scientists by receiving the Canada Gairdner Wightman Award.
In response to the state of public health emergency declared in the Province of Québec due to the COVID-19 pandemic on Friday March 13, 2020, McGill University has requested that all non- essential research activities ramp down until further notice to restrict the presence of research staff and research participants on site.
March 27: The Neuro has an outbreak of COVID-19 with 7 positive test results amongst hospital staff in the last few days. Public Health is aware of the situation.
PRAXAIR - Delivery of Dry Ice, Liquid Nitrogen Tanks, and Gas Cylinders (CO2) to The Neuro during the research ramp-down period
EACH LAB MUST DESIGNATE A PERSON IN CHARGE OF THE FOLLOWING STEPS
PRAXAIR DRY ICE
- The standard order for delivery of dry ice to the 7th floor freezer on Mondays is continuing. Report any issues to Linda Michel (linda.michel [at] mcgill.ca)
Mail Room
Receives all Canada Post packages only and internal mail
Room: RVH - E.372
Dispatch Center Phone:
514 934-1934 Ext. 54000
Dial “4” for Neuro
Leave message only
Operating hours
7 am to 8 pm
Monday to Friday
Delivery Rounds
Monday, Wednesday, Friday, around noon
Update: Wednesday, March 25
Please see this updated memo with information about PRAXAIR and MEGS deliveries.
Study suggests humans have developed complementary neural systems in each hemisphere for auditory stimuli
Speech and music are two fundamentally human activities that are decoded in different brain hemispheres. A new study used a unique approach to reveal why this specialization exists.
Open source app helps predict brain tumour malignancy and patient survival
The power of artificial intelligence (AI) in medicine lies in its ability to find important statistical patterns in large datasets. A study published today is an important proof of concept for how AI can help doctors and brain tumour patients make better treatment decisions.
New technique could be used to choose best therapies for patients and measure their effectiveness
Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient’s progression is different. A new study shows artificial intelligence (AI) analysis of blood samples can predict and explain disease progression, which could one day help doctors choose more appropriate and effective treatments for patients.
Q1K: A collaborative undertaking involving 1,000 families to transform autism care